In Brief: Enamelon
This article was originally published in The Tan Sheet
Executive Summary
Enamelon: Receives patent for formulation of soluble calcium and phosphate with fluoride as well as for the formulation's application for the remineralization of teeth. Soluble calcium acts in a manner similar to Enamelon's patented "amorphous" calcium formulation/application, the company says: the amorphous calcium changes from solid to liquid form, then recrystallizes once it is deposited in lesions in tooth enamel. The company will begin test marketing products containing the remineralization technology in the first quarter of 1997, followed by a predicted national launch in early 1998 ("The Tan Sheet" July 8, p. 5)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning